| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $24.4M | -1.5% |
| Cost of Revenue | $13.7M | -0.2% |
| Gross Profit | $10.7M | -3.1% |
| R&D Expense | $3.8M | -14.0% |
| SG&A Expense | $18.7M | +32.3% |
| Operating Income | -$35.7M | -16.8% |
| Pre-tax Income | -$54.1M | -31.3% |
| Income Tax | $7K | -75.0% |
| Net Income | -$53.9M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $13.2M | -31.3% |
| Accounts Receivable | $2.3M | -30.2% |
| Inventory | $3.9M | +1.5% |
| Current Assets | $26.2M | -16.3% |
| Total Assets | $36.1M | -16.8% |
| Current Liabilities | $37.8M | -12.2% |
| Long-term Debt | $22.6M | -4.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$22.7M | -4.1% |
| Capital Expenditures | $654K | +89.0% |
| Investing Cash Flow | -$474K | -103.3% |
| Financing Cash Flow | $17.1M | +73.7% |
| Free Cash Flow | -$23.3M | -5.4% |
| -43.3% |
| EPS (Basic) | -$1.86 | +10.1% |
| EPS (Diluted) | -$1.86 | +10.1% |
| Total Liabilities |
| $82.4M |
| +0.4% |
| Stockholders' Equity | -$46.3M | -19.8% |